Boyd Peter E. Insider Trading Activity

Average Profitability
43.71%
Insider Buys Quantity
5
Insider Buys Sum
$17,815.28
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Boyd Peter E.

According to the SEC Form 4 filings, Boyd Peter E., being in a position of

  1. Chief People Officer at Aquestive Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 29814 shares for $124,414,
    over all time since 2018-11-21, has bought 12893 shares for $17,815, and sold 64814 shares for $336,914.

Biography of Boyd Peter E.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $124,4141100

Comparison of Insiders on Amount of Buys and Sells

2026-03-10SaleAquestive Therapeutics, Inc.
AQST
Chief People Officer
29,814
0.0292%
$4.17$124,414-0.48%
2025-10-15SaleAquestive Therapeutics, Inc.
AQST
See Remarks
10,000
0.0096%
$7.00$70,000-42.23%
2025-09-26SaleAquestive Therapeutics, Inc.
AQST
See Remarks
10,000
0.0105%
$6.30$63,000-29.22%
2025-09-05SaleAquestive Therapeutics, Inc.
AQST
See Remarks
15,000
0.0147%
$5.30$79,500-21.77%
2022-06-14PurchaseAquestive Therapeutics, Inc.
AQST
SVP-Bus. Process & Info. Tech.
5,000
0.0107%
$0.81$4,050+11.38%
2022-06-08PurchaseAquestive Therapeutics, Inc.
AQST
SVP-Bus. Process & Info. Tech.
2,293
0.0054%
$0.96$2,201+2.89%
2020-03-16PurchaseAquestive Therapeutics, Inc.
AQST
4,000
0.0058%
$0.75$3,000+246.43%
2019-08-12PurchaseAquestive Therapeutics, Inc.
AQST
1,200
0.0046%
$3.81$4,572+6.77%
2018-11-21PurchaseAquestive Therapeutics, Inc.
AQST
400
0.0019%
$9.98$3,992-48.92%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.